关注
Subhasree Nag
Subhasree Nag
Texas Tech University Health Sciences Center, Pacific Northwest National Laboratory
在 ttuhsc.edu 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
The MDM2-p53 pathway revisited
S Nag, J Qin, KS Srivenugopal, M Wang, R Zhang
Journal of biomedical research 27 (4), 254, 2013
4312013
Ginsenosides as Anticancer Agents: In vitro and in vivo Activities, Structure–Activity Relationships, and Molecular Mechanisms of Action
SA Nag, JJ Qin, W Wang, MH Wang, H Wang, R Zhang
Frontiers in pharmacology 3, 25, 2012
3552012
Targeting the NFκB signaling pathways for breast cancer prevention and therapy
W Wang, SA Nag, R Zhang
Current medicinal chemistry 22 (2), 264-289, 2015
2372015
Ribosomal proteins and human diseases: pathogenesis, molecular mechanisms, and therapeutic implications
W Wang, S Nag, X Zhang, MH Wang, H Wang, J Zhou, R Zhang
Medicinal research reviews 35 (2), 225-285, 2015
2132015
NFAT as cancer target: mission possible?
JJ Qin, S Nag, W Wang, J Zhou, WD Zhang, H Wang, R Zhang
Biochimica Et Biophysica Acta (BBA)-Reviews on Cancer 1846 (2), 297-311, 2014
1532014
Targeting MDM2-p53 interaction for cancer therapy: are we there yet?
S Nag, X Zhang, KS Srivenugopal, MH Wang, W Wang, R Zhang
Current medicinal chemistry 21 (5), 553-574, 2014
1422014
Polycomb group (PcG) proteins and human cancers: multifaceted functions and therapeutic implications
W Wang, JJ Qin, S Voruganti, S Nag, J Zhou, R Zhang
Medicinal research reviews 35 (6), 1220-1267, 2015
1322015
Natural Product Ginsenoside 25-OCH3-PPD Inhibits Breast Cancer Growth and Metastasis through Down-Regulating MDM2
W Wang, X Zhang, JJ Qin, S Voruganti, SA Nag, MH Wang, H Wang, ...
PLoS One 7 (7), e41586, 2012
962012
The pyrido[b]indole MDM2 inhibitor SP-141 exerts potent therapeutic effects in breast cancer models
W Wang, JJ Qin, S Voruganti, KS Srivenugopal, S Nag, S Patil, H Sharma, ...
Nature communications 5 (1), 5086, 2014
932014
Ginsenoside Rh1: a systematic review of its pharmacological properties
DNH Tam, DH Truong, TTH Nguyen, L Tran, HD Nguyen, ...
Planta Medica 84 (03), 139-152, 2018
832018
Oral nano-delivery of anticancer ginsenoside 25-OCH3-PPD, a natural inhibitor of the MDM2 oncogene: Nanoparticle preparation, characterization, in vitro and in vivo anti …
S Voruganti, JJ Qin, S Sarkar, S Nag, IA Walbi, S Wang, Y Zhao, W Wang, ...
Oncotarget 6 (25), 21379, 2015
662015
Natural product MDM2 inhibitors: anticancer activity and mechanisms of action
JJ Qin, S Nag, S Voruganti, W Wang, R Zhang
Current medicinal chemistry 19 (33), 5705-5725, 2012
652012
RYBP expression is associated with better survival of patients with hepatocellular carcinoma (HCC) and responsiveness to chemotherapy of HCC cells in vitro and in vivo
W Wang, J Cheng, JJ Qin, S Voruganti, S Nag, J Fan, Q Gao, R Zhang
Oncotarget 5 (22), 11604, 2014
562014
Selective cytotoxicity, inhibition of cell cycle progression, and induction of apoptosis in human breast cancer cells by sesquiterpenoids from Inula lineariifolia Turcz.
JJ Qin, HZ Jin, Y Huang, SD Zhang, L Shan, S Voruganti, S Nag, W Wang, ...
European journal of medicinal chemistry 68, 473-481, 2013
452013
miRNAs in cancer prevention and treatment and as molecular targets for natural product anticancer agents
B Qian, SA Nag, Y Su, S Voruganti, JJ Qin, R Zhang, W Cho
Current cancer drug targets 13 (5), 519-541, 2013
352013
KCN1, a Novel Synthetic Sulfonamide Anticancer Agent: In Vitro and In Vivo Anti-Pancreatic Cancer Activities and Preclinical Pharmacology
W Wang, L Ao, ER Rayburn, H Xu, X Zhang, X Zhang, SA Nag, X Wu, ...
Public Library of Science 7 (9), e44883, 2012
332012
In vitro metabolism of benzo[a]pyrene-7,8-dihydrodiol and dibenzo[def,p]chrysene-11,12 diol in rodent and human hepatic microsomes
RAC Smith JN, D Mehinagic, S Nag, SR Crowell
Toxicology Letters 269, 23-32, 2017
202017
Benzo[a]pyrene Induction of Glutathione S-Transferases: An Activity-Based Protein Profiling Investigation
EG Stoddard, BJ Killinger, SA Nag, J Martin, R Corley, JN Smith, ...
Chemical research in toxicology 32 (6), 1259-1267, 2019
172019
Development and validation of a rapid HPLC method for quantitation of SP‐141, a novel pyrido [b] indole anticancer agent, and an initial pharmacokinetic study in mice
S Nag, JJ Qin, S Voruganti, MH Wang, H Sharma, S Patil, JK Buolamwini, ...
Biomedical Chromatography 29 (5), 654-663, 2015
142015
Exposure to an environmental mixture of polycyclic aromatic hydrocarbons induces hepatic cytochrome P450 enzymes in mice
EG Stoddard, S Nag, J Martin, KJ Tyrrell, T Gibbins, KA Anderson, ...
Chemical research in toxicology 34 (9), 2145-2156, 2021
132021
系统目前无法执行此操作,请稍后再试。
文章 1–20